SMART-SCOTLAND feasibility study award “Discovery of colorectal cancer biomarkers and validation of antibodies towards them for use as diagnostic or therapeutic agents”. Over the duration of 18 months and in collaboration with Professor Graeme Murray at Aberdeen University, the projects aims to deliver a portfolio of novel tumour biomarkers combined with clinical probes for diagnostic, prognostic, treatment predictive, monitoring and therapeutic use to colorectal cancer. When successful such platform will provide a tumour biomarker discovery platform for other types of cancer (more update to follow).
Kristina Whitfield2018-08-01T14:27:44+00:00November 13th, 2014|News|
EpitoGen Technology News
May 11th, 2021